Original Research

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain

Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S

ClinicoEconomics and Outcomes Research 2018, 10:747-759

Published Date: 12 November 2018